Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Introductory guidance on choosing long-term holds for beginners, focusing on fundamentals, liquidity, and project viability.
27,784 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Microsoft is at a crossroads as investors await the July 29 results. This article dives into why the stock could rebo...
Coal stocks moved higher as energy markets tensed. This piece breaks down why peabody energy other coal names jumped,...
As investors eye StepStone's Q4 2026 earnings, understanding revenue mix, margin dynamics, and guidance becomes essen...
Peloton stock popped today as traders weighed potential index moves and improving momentum. This guide breaks down th...
When a biotech stock jumps after a conference, investors want to know if it’s sustainable. This article breaks down w...
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
A dramatic 1034% rally can lure buyers, but momentum alone doesn’t ensure value. This guide breaks down how to assess...
Thinking about retirement by the end of 2026? This guide outlines three essential moves to secure your financial foun...
Base's move away from the OP Stack sent shockwaves through the crypto market. This article explains why optimism plun...
March is a pivotal time for industrial stocks as infrastructure and defense themes collide with energy transition dem...
A single photo can trigger a flood of online chatter and real-world money decisions. This piece breaks down what a vi...